Methyl 2-[4-(Bromomethyl)phenyl]benzoate CAS 114772-38-2 Purity >99.0% (HPLC) Telmisartan Intermediate Factory
Ruifu Chemical Supple Telmisartan intermedia Cum Puritate
Telmisartan CAS 144701-48-4
Methyl 2-(p-Tolyl)benzoate CAS 114772-34-8
2-(p-Tolyl) Acidum benzoicum CAS 7148-03-0
Telmisartan Benzimidazole Acidum CAS 152628-03-0
Telmisartan Methyl Ester CAS 528560-93-2
Methyl 2-[4-(Bromomethyl)phenyl]benzoate CAS 114772-38-2
Methyl 4-(Butyrylamino) -3-Methyl-5-Nitrobenzoate CAS 152628-01-8
2-n-Propyl-4-Methyl-6-(1-Methylbenzimidazole-2-yl)benzimidazole CAS 152628-02-9
Nomen chemicum | Methyl 2-[4-(Bromomethyl)phenyl]benzoate |
Synonyma | 2-[4-(Bromomethyl)phenyl]benzoicum acidum Methyl Ester;Methyl 4'- (Bromomethyl) biphenyl-2-carboxylata;4'-(Bromomethyl) biphenyl-2-carboxylic Acidum Methyl Ester |
CAS Number | 114772-38-2 |
CATTUS Number | RF-PI1879 |
Stock Status | In Stock, Productio Capacitas 150MT/Annus |
Formulae hypotheticae | C15H13BrO2 |
M. Pondus | 305.17 |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Alba ad lux Yellow Crystalline pulveris |
Claritas | Hyalina et diaphana, sine substantiis externis |
Puritas / Analysis Methodus | >99.0% (HPLC) |
Liquescens punctum | 48.0~57.0℃ |
Damnum in Siccatio | <0.50% |
Residere in Ignition | <0.20% |
una immunditia | <0.50% |
Totalis immunditias | <1.00% |
Metalla gravia (ut Pb) | <20ppm |
Proton NMR Spectrum | Conformat ut Structure |
Test Standard | Enterprise Standard |
Consuetudinem | Medium Telmisartanum (CAS: 144701-48-4) |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
Methyl 2-[4-(Bromomethyl)phenyl]benzoate (CAS: 114772-38-2), intermedia pharmaceutica, in serie APIs sartan producenda adhibita.Methyl 2-[4-(Bromomethyl)phenyl]benzoate est medius Telmisartan (CAS: 144701-48-4).Telmisartan est angiotensin II receptaculum obstructorem (ARB) habens affinitatem angiotensin II receptoris generis 1 (AT1).Telmisartan impedit ligamen angiotensin II ad AT1 receptores in musculi vasculari lenis et sic vetat actionem vasoconstrictam angiotensin II.Telmisartan primum a societate pharmaceutica Germanorum Boehringer Ingelheim formata est.Telmisartan in US ad hypertensionem tractandam inmissus est.Solo aut coniuncto cum aliis antihypertensivis generibus ad curationem hypertensionis adhibita.